CARv3-TEAM-E T cells（Massachusetts General Hospital）

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameCARv3-TEAM-E T cells（Massachusetts General Hospital）
Drug Alias NameAutologous T lymphocytes
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGlioblastomaGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMassachusetts General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesMassachusetts General Hospital
Inactive CompaniesN/A
Active IndicationsGlioblastomaGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A